Core Viewpoint - Wuzhou Medical's stock closed at 43.85 yuan, up 3.03%, with a rolling PE ratio of 83.48, marking a new low in 481 days, and a total market value of 2.982 billion yuan [1] Group 1: Company Overview - Wuzhou Medical specializes in the research, manufacturing, and sales of disposable sterile infusion medical devices and other related medical supplies [1] - The main products include syringes, safety syringes, insulin syringes, infusion devices, blood transfusion devices, and various types of needles [1] Group 2: Financial Performance - For Q1 2025, Wuzhou Medical reported revenue of 104 million yuan, a year-on-year increase of 15.59%, while net profit was 5.6345 million yuan, reflecting a year-on-year decrease of 43.00% [1] - The gross profit margin for sales was 14.62% [1] Group 3: Shareholder Information - As of July 31, 2025, Wuzhou Medical had 7,255 shareholders, an increase of 848 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 4: Industry Comparison - The average PE ratio for the medical device industry is 57.51, with a median of 41.25, placing Wuzhou Medical at 101st in the industry ranking [1][2] - The industry average market value is 120.28 billion yuan, while Wuzhou Medical's market value is significantly lower at 2.982 billion yuan [2]
五洲医疗收盘上涨3.03%,滚动市盈率83.48倍,总市值29.82亿元